Wednesday, July 8, 2026

biotech · Dental Caries · Cystic Fibrosis · ARMP

Armata Pharmaceuticals

Armata Pharmaceuticals is a biotech organization headquartered in Freehold, USA. It trades on NYSE under ticker ARMP. Primary therapeutic focus areas include Dental Caries, Cystic Fibrosis, Non-cystic Fibrosis Bronchiect

Freehold, USA HQ
2018 Founded
18 Employees
Public company Type
ARMP · NYSE Ticker
Company details
Status
Public
HQ
Freehold, USA
Founded
2018
Employees
18
Programs
9
Drugs
0
Patents
5
Clinical program

AB-SA01 (10^8 PFU per phage)

Phase 1 · mab · Healthy Volunteers

AB-SA01 (10^8 PFU per phage) for Healthy Volunteers is a Phase 1 program (mab) at Armata Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Internal code AB-SA01-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Armata Pharmaceuticals
Phase
Phase 1
Modality
mab
Indication
Healthy Volunteers
Status
completed
Trials
1

Clinical trials